This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Marriage may protect against heart ... A global study led by Keele University has found that marriage ... (20 Jun 2018)
Risk of burnout can be estimated by ... According to calculations from the World Health Organisation, ... (20 Jun 2018)
Obesity in women and current smoking in men ... Study shows 46% of women and 38% of men with early rheumatoid ... (20 Jun 2018)
Study suggests siblings of patients with ...  Patients with rheumatoid arthritis and their siblings were 44% ... (19 Jun 2018)
Gout in the elderly linked to higher risk of ... The results of a study presented at the Annual European Congress ... (20 Jun 2018)
Friday, 09 September 2016 00:00

Mammographic Technology used for Breast Cancer Screening

Written by
Rate this item
(0 votes)

Pierre Vassallo

Breast cancer, the most common cancer in women (1 in 8 women develops breast cancer), has generated considerable interest in the literature with the result that Breast Cancer
Screening Programmes have become the norm in developed countries. The aim of these screening programs is to achieve early detection of breast cancer in women who have not yet developed any symptoms. Such early detection would allow early treatment, which is necessary to achieve a good treatment outcome. It has been shown that treatment of early cancer results in cure in 98% of cases, while late cancer detection results in a poor outcome. 

Early breast cancer detection depends on the accuracy of the equipment used and on training and experience of the specialists involved. Equipment accuracy and consequently image quality play a very important role as specialist training and experience do not compensate for poor image quality. There is considerable scientific evidence confirming the advantages of digital mammography over conventional film-screen mammography.

Film-screen mammography uses a chemically processed film to record images of the breast. On the othr hand, there are two different technologies used in digital mammography, computed radiography (CR) or full-field digital mammography (FFDM).

CR is a technology that obtains an image of the breast through exposure of a fluorescent plate, which is then scanned in a dedicated laser scanner to obtain a digital image of the
breast (Fig 1).  

In contrast, FFDM technology uses an array of tiny solidstate electronic detectors embedded in the base plate of the mammography machine; the image of the breast obtained
by these tiny detectors is transferred directly to a specialised computer workstation for viewing (Fig 2).

CR uses an intermediate step in processing, namely the fluorescent plate; this significantly degrades image quality. FFDM, a significantly more expensive technology, obtains
images that are far superior to CR mammography (Fig 3).

FFDM has consistently been shown to be more accurate for detecting cancer than CR or conventional film-screen technology and is now considered the gold standard of mammography. In addition, FFDM uses 25-65% less radiation and is therefore much safer than other technologies. FFDM breast cancer screening has a high detection rate for
cancers particularly those containing calcifications (Fig 4a), most of which represent an early-stage cancer known as ductal carcinoma in situ (DCIS). Microcalcifications are defined as calcifications each measuring ≤0.5mm in diameter, and are particularly suspicious when >5 in number within an area ≤1cm in diameter, especially when distributed in a linear and branching (ductal) pattern and when they have a fragmented in a dedicated laser scanner to obtain a digital image of the breast (Fig 1).

In contrast, FFDM technology uses an array of tiny solidstate electronic detectors embedded in the base plate of the mammography machine; the image of the breast obtained
by these tiny detectors is transferred directly to a specialised computer workstation for viewing (Fig 2).

CR uses an intermediate step in processing, namely the fluorescent plate; this significantly degrades image quality. FFDM, a significantly more expensive technology, obtains
images that are far superior to CR mammography (Fig 3).

FFDM has consistently been shown to be more accurate for detecting cancer than CR or conventional film-screen technology and is now considered the gold standard of
mammography. In addition, FFDM uses 25-65% less radiation and is therefore much safer than other technologies.  FFDM breast cancer screening has a high detection rate for
cancers particularly those containing calcifications (Fig 4a), most of which represent an early-stage cancer known as ductal carcinoma in situ (DCIS). Microcalcifications are defined as calcifications each measuring ≤0.5mm in diameter, and are particularly suspicious when >5 in number within an area ≤1cm in diameter, especially when distributed in a linear and branching (ductal) pattern and when they have a fragmented appearance. Microcalcifications may be very subtle (Figure 4b) and should raise clinical suspicion even at this stage. The visibility of microcalcifications is improved on FFDM compared with CR and film-screen mammography (Fig 5).

Invasive breast cancers, which are more advanced than DCIS, may also contain calcifications. In fact, around 35% of cancers detected on the basis of the presence calcifications are
invasive breast cancers.

Invasive cancers detected on the basis of calcifications in population-based digital mammographic screening also tend to be smaller (median, 7 mm) than those detected on the basis
of mass (median, 14mm), architectural distortion (median, 15mm), or combinations of both features (median, 17mm).

In addition, invasive cancers detected through the presence of calcifications noted on FFDM share the same degree of aggressiveness as those detected on CR and film-screen
mammography; in other words, we are not detecting less aggressive and maybe less significant cancers with FFDM. Nevertheless, the calcification-based detection rate for invasive
cancers in population-based screening is higher with FFDM than with CR or film-screen mammography.

The improved image quality of FFDM does not contribute only to detection of breast calcifications. Subtle areas of architectural distortion are also better seen and are often the
only sign of early malignant disease (Fig 6).

In summary, mammography is a valuable tool in the detection of early breast cancer and is our primary modality in breast cancer screening. The accuracy of mammographic
technology however, varies depending on the method used. FFDM performs significantly better and has become the gold standard for use in breast cancer screening. CR and film-screen mammography although still widely available and in common use, should be replaced by FFDM as these technologies no longer meet the standards expected in today’s clinical practice.

Fig-1a 1405

Figure 1a: CR mammography machine takes a cassette containing a fluorescent plate in the cassette holder (arrow).

Fig-1b 1405

Figure 1b. The CR laser reader withdraws the fluorescent plate from the cassette and scans it.

Fig-2 1405

Figure 2: FFDM machine contains an array of micro detectors in the base plate (arrow).

Fig-3 1405

Figure 3: Comparison of CR versus FFDM: noted the sharper and more detailed image obtained by FFDM compared to CR.

Fig-4a 1405

Figure 4a. Obvious microcalcifications distributed in a linear and branching pattern (arrows).

Fig-4b 1405

Figure 4b. More subtle fragmented microcalcifications in early DCIS (circles).

Fig-5 1405

Figure 5: Comparison of microcalcifications seen on CR versus FFDM.

Fig-6 1405

Figure 6. Very subtle early invasive ductal cancer detected through minimal architectural distortion (arrow) on FFDM. Th

Additional Info

  • TheSynapse Magazines: 2014
Read 2109 times Last modified on Tuesday, 01 November 2016 21:46

Dr Pierre Vassallo MD PhD FACA Artz fur Radiologie specialised in radiology at the Institute of Clinical Radiology at the University of Muenster, Germany and the Memorial Sloan-Kettering Cancer Center, New York, US. He is currently Consultant Radiologist and Managing Director at DaVinci Health, Malta.

More in this category: « A Doctor in the Making

TheSynapse Videos

0
0
0
0
0
0

Highlights

  • WASP Course in Bahrain

    WASP Course, led by Prof Victor Grech and Prof Charles Savona Ventura, has recently organised a course in Bahrain. Co-hosted with Arabian Gulf University, the course, on how to write a scientific paper, focused on quantitative analysis methods and was targeted for medical doctors and allied health professionals.

    Written on April 24, 2018 Read more...

SPONSOR MESSAGE

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…